Skip to main content

Table 1 Sample characteristics stratified for severity of depressive symptoms (N = 14.499)

From: Associations between degree and sub-dimensions of depression and metabolic syndrome (MetS) in the community: results from the Gutenberg Health Study (GHS)

 

Depressive symptoms (PHQ score)

 

0–4

5–9

10–14

15–27

 

no

minimal

mild

moderately severe/severe

Number

9403 a

3977

846

273

Sex, female

45.3%

56.7%

59.8%

61.2%

Age, in years; mean (SD)

55.2 (11.2)

54.4 (11.0)

53.1 (10.3)

51.7 (9.8)

SES, (3–21), median (1st/ 3rd quartile)

13.0 (10/17))

12.0 (9/16)

11.0 (9/15)

11.0 (8/14)

Current smoker

17.9%

21.0%

27.1%

30.1%

Depressive symptoms

 Somatic-affective, median (1st/ 3rd quartile)

1 (1/2)

4 (3/4)

6 (5/7)

9 (7/10)

 Cognitive-affective, median (1st,/3rd quartile)

0 (0/1)

3 (2/4)

5 (4/6)

9 (8/10)

Any anxiety

3.7%

19.5%

56.4%

86.4%

Psychopharmacological treatment

4.9%

12.4%

24.6%

43.2%

Somatic conditions

 Risk determinants of MetS median (1st/3rd quartile)

2 (1/3)

2 (1/3)

2 (1/3)

2 (1/3)

Metabolic syndrome (full criteria)

32.0%

32.7%

34.4%

41.8%

 High triglycerides(> = 150 mg/dl or on drug treatment for increased triglycerides)

23.8%

25.4%

26.8%

33.0%

 Low HDL (< 40 mg/dl in men and < 50 mg/dl in women)

16.9%

18.6%

27.1%

25.5%

 Hypertension(> 130 mmHg systolic or > 85 mmHg diastolic or on antihypertensive drug treatment)

65.3%

62.9%

61.1%

65.3%

 Central obesity(waist circumference > 88 cm in women and > 94 cm in men)

67.0%

70.4%

74.3%

78.0%

 High fasting blood glucose(> = 100 mg/dl or on drug treatment for increased glucose)

21.8%

19.5%

18.5%

17.2%

 Diabetes

8.5%

9.8%

11.5%

11.8%

 Obesity (BMI > =30)

23.0%

26.9%

30.5%

38.6%

 Atrial fibrillation

2.6%

2.8%

2.4%

3.3%

 CHD

3.9%

4.7%

5.4%

5.9%

 Myocardial infarction

2.6%

3.5%

2.7%

3.3%

 PAOD

2.8%

4.0%

5.1%

6.4%

 Stroke

1.6%

1.9%

3.0%

1.8%

 Cancer

8.5%

10.1%

10.2%

7.0%

Health care utilization (last 4 weeks)

 Consulted somatic physicians

39.3%

46.8%

57.1%

64.0%

 Consulted psychiatrists

0.2%

0.5%

2.1%

9.2%

 Consulted psychotherapists

0.4%

0.9%

3.7%

8.1%

  1. a A total of 511 participants were excluded from analyses because of missing data: 278 participants had missings in PHQ-9; 249 participants had missings in parameters necessary for the determination of MetS, mostly fasting blood glucose in 238 participants